FBLIM1 and central nervous system cancer: To further explore the diagnostic value of FBLIM1 expression for glioma, we performed ROC assays and found that FBLIM1 could effectively distinguish glioma specimens from normal tissue samples (AUC: 0.826; 95% CI: 0.807–0.845; p < 0.001, Figure 1d).